Matthew B. Frieman

23.3k citations

112 papers · 10.1k indexed · 7 hit papers · h-index 55

Infectious Diseases top 0.05%
- SARS-CoV-2 and COVID-19 Research 72
- COVID-19 Clinical Research Studies 29
- Viral gastroenteritis research and epidemiology 16
- Viral Infections and Outbreaks Research 10
Animal Science and Zoology top 0.1%
- Animal Virus Infections Studies 26
Immunology top 1%
- interferon and immune responses 15
Modeling and Simulation top 1%
- COVID-19 epidemiological studies 8
Neurology top 1%
Epidemiology
- Respiratory viral infections research 10

Co-authors: Christopher M. Coleman Ralph S. Baric Peter Palese Sarah A. Kopecky-Bromberg Mark T. Heise Thiagarajan Venkataraman Kirsten Kulcsar Boyd L. Yount
Cited by: Infectious Diseases Animal Science and Zoology Immunology
Journals: Proceedings of the National Academy of Sciences (3 papers)JAMA (1 paper)Nature Communications (3 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Matthew B. Frieman

110 papers receiving 9.9k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2021 JAMA
2020 ACS Nano
2019 Viruses
2019 JCI Insight
2014 Antimicrobial Agents and Chemotherapy
2014 Antimicrobial Agents and Chemotherapy
2006 Journal of Virology

Peers

Countries citing papers authored by Matthew B. Frieman

Since Specialization

Citations

This map shows the geographic impact of Matthew B. Frieman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Frieman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Frieman more than expected).

Fields of papers citing papers by Matthew B. Frieman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Frieman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Frieman. The network helps show where Matthew B. Frieman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew B. Frieman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew B. Frieman Line = papers co-authored together Matthew B. Frieman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of Nirmatrelvir/Ritonavir Treatment and COVID-19-Neutralizing Antibody Titers in a Longitudinal Health Care Worker Cohort Open Forum Infectious Diseases ·Slade Decker,Shaoming Xiao,Carly Dillen,Christina Schumacher,Aaron M. Milstone,Matthew B. Frieman,Amanda K. Debes	2024	1
2	Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2 Journal of Virology ·Robert M. Johnson,Jeremy Ardanuy,Holly Hammond,James Logue,Lian Jackson,Lauren Baracco,Marisa E. McGrath,Carly Dillen,Nita Patel,Gale Smith,Matthew B. Frieman	2023	9
3	Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses mBio ·Jeremy Ardanuy,Robert M. Johnson,Carly Dillen,Louis J. Taylor,Holly Hammond,Stuart Weston,Matthew B. Frieman	2023	3
4	SIRT-1 is required for release of enveloped enteroviruses eLife ·Alagie Jassey,James Logue,Stuart Weston,Michael A. Wagner,Ganna Galitska,Katelyn Miller,Matthew B. Frieman,William T. Jackson	2023	3
5	Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq Nature Communications ·Sara Sunshine,Andreas S. Puschnik,Joseph M. Replogle,Matthew T. Laurie,Jamin Liu,Beth Shoshana Zha,James K. Nuñez,Janie R. Byrum,Aidan H. McMorrow,Matthew B. Frieman,Juliane Winkler,Xiaojie Qiu,Oren S. Rosenberg,Manuel D. Leonetti,Chun Ye,Jonathan S. Weissman,Joseph L. DeRisi,Marco Y. Hein	2023	12
6	SIRT-1 is required for release of enveloped enteroviruses eLife ·Alagie Jassey,James Logue,Stuart Weston,Michael A. Wagner,Ganna Galitska,Katelyn Miller,Matthew B. Frieman,William T. Jackson	2023	1
7	SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection mBio ·Minghua Li,Kasirajan Ayyanathan,Mark Dittmar,Jesse Miller,Iulia Tapescu,Jae Seung Lee,Marisa E. McGrath,Yong Xue,Sanjay Vashee,D. Schultz,Matthew B. Frieman,Sara Cherry	2023	8
8	Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants Clinical Infectious Diseases ·Jianyu Lai,Kristen K. Coleman,Sheldon Tai,Jennifer German,Filbert Hong,Barbara Albert,Yi Esparza,Aditya K. Srikakulapu,Maria Schanz,Isabel Sierra Maldonado,Molly Oertel,Naja Fadul,T. Louis Gold,Stuart Weston,Kristin Mullins,Kathleen McPhaul,Matthew B. Frieman,Donald K. Milton	2022	30
9	Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease npj Vaccines ·Bennett Davenport,Alexis Catala,Stuart Weston,Robert M. Johnson,Jeremy Ardanuy,Holly Hammond,Carly Dillen,Matthew B. Frieman,Carlos E. Catalano,Thomas E. Morrison	2022	16
10	SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis Proceedings of the National Academy of Sciences ·Marisa E. McGrath,Yong Xue,Carly Dillen,Lauren M. Oldfield,Nacyra Assad-Garcia,Jayshree Zaveri,Natasha Singh,Lauren Baracco,Louis J. Taylor,Sanjay Vashee,Matthew B. Frieman	2022	33
11	Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses mBio ·Judith M. White,Joshua T. Schiffer,Rachel Bender Ignacio,Shuang Xu,Denis E. Kainov,Aleksandr Ianevski,Tero Aittokallio,Matthew B. Frieman,Gene G. Olinger,Stephen J. Polyak	2021	42
12	Viral RNA and Infectious Influenza Virus on Mobile Phones of Patients With Influenza in Hong Kong and the United States The Journal of Infectious Diseases ·Jingyi Xiao,P. Jacob Bueno de Mesquita,Nancy Leung,Oluwasanmi Adenaiye,Sheldon Tai,Matthew B. Frieman,Filbert Hong,Daniel K. W. Chu,Dkm Ip,Benjamin J. Cowling,Donald K. Milton	2021	3
13	Development and deployment of COVID-19 vaccines for those most vulnerable Science Translational Medicine ·Wayne C. Koff,Theodore Schenkelberg,Tere Williams,Ralph S. Baric,Adrian B. McDermott,Cheryl Cameron,Mark J. Cameron,Matthew B. Frieman,Gabriele Neumann,Yoshihiro Kawaoka,Alyson A. Kelvin,Ted M. Ross,Stacey Schultz‐Cherry,Timothy D. Mastro,Frances Priddy,Penny L. Moore,Julie Ostrowsky,Michael T. Osterholm,Jaap Goudsmit	2021	51
14	Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients Nature Communications ·Simon G. P. Funnell,William E. Dowling,César Muñoz‐Fontela,Pierre-Stéphane Gsell,Donald E. Ingber,Geraldine A. Hamilton,Leen Delang,Joana Rocha‐Pereira,Suzanne J. F. Kaptein,Kai Dallmeier,Johan Neyts,Kyle Rosenke,Emmie de Wit,Heinz Feldmann,Pauline Maisonnasse,Roger Le Grand,Matthew B. Frieman,Christopher M. Coleman	2020	37
15	CD8 ⁺ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome Journal of Virology ·Christopher M. Coleman,Jeanne M. Sisk,Gábor Halász,Jixin Zhong,Sarah E. Beck,Krystal Matthews,Thiagarajan Venkataraman,Sanjay Rajagopalan,Christos A. Kyratsous,Matthew B. Frieman	2016	46
16	Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection Proceedings of the National Academy of Sciences ·Kristen E. Pascal,Christopher M. Coleman,Alejandro O. Mujica,Vishal Kamat,Ashok Badithe,Jeanette Fairhurst,Charleen Hunt,John Strein,Alexander A. Berrebi,Jeanne M. Sisk,Krystal Matthews,Robert Babb,Gang Chen,Ka-Man V. Lai,Tammy Huang,William C. Olson,George D. Yancopoulos,Neil Stahl,Matthew B. Frieman,Christos A. Kyratsous	2015	172
17	Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysisbreakdown → Antimicrobial Agents and Chemotherapy ·Jason Kindrachuk,Britini L. Ork,Brit J. Hart,Steven Mazur,Michael R. Holbrook,Matthew B. Frieman,Dawn Traynor,Reed F. Johnson,Julie Dyall,Jens H. Kuhn,Gene G. Olinger,Lisa E. Hensley,Peter B. Jahrling	2014	307
18	Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling Journal of Virology ·Matthew B. Frieman,Kiira Ratia,Robert E. Johnston,Andrew D. Mesecar,Ralph S. Baric	2009	293
19	Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection Journal of Virology ·Barry Rockx,Tracey Baas,Gregory A. Zornetzer,Bart L. Haagmans,Timothy P. Sheahan,Matthew B. Frieman,Matthew D. Dyer,Thomas H. Teal,Sean Proll,Judith M. A. van den Brand,Ralph S. Baric,Michael G. Katze	2009	137
20	Glycan microarray analysis of Candida glabrata adhesin ligand specificity Molecular Microbiology ·Margaret L. Zupancic,Matthew B. Frieman,David F. Smith,Richard Alvarez,Richard D. Cummings,Brendan P. Cormack	2008	112

About Matthew B. Frieman

Matthew B. Frieman is a scholar working on Infectious Diseases, Animal Science and Zoology and Modeling and Simulation, having authored 112 papers that have together received 10.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (72 papers), COVID-19 Clinical Research Studies (29 papers), Animal Virus Infections Studies (26 papers), Viral gastroenteritis research and epidemiology (16 papers), interferon and immune responses (15 papers), Respiratory viral infections research (10 papers), Viral Infections and Outbreaks Research (10 papers) and COVID-19 epidemiological studies (8 papers). The work is most often cited by research in Infectious Diseases (7.0k citations), Animal Science and Zoology (1.7k citations) and Immunology (1.8k citations). Matthew B. Frieman has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Christopher M. Coleman, Ralph S. Baric, Peter Palese, Sarah A. Kopecky-Bromberg, Mark T. Heise, Thiagarajan Venkataraman, Kirsten Kulcsar, Boyd L. Yount, Ketan Dighe and Parikshit Moitra. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact